Healia Clinical Trials Information Database

Efficacy of Massage at the End of Life

The purpose of this study is to determine whether massage therapy is effective in reducing pain and distress and improving quality of life among cancer patients at life’s end.

Description

Relieving physical and emotional symptoms is a key component of end-of-life care. Despite care, terminally ill patients are still significantly burdened by unrelieved symptoms. Therapies that have potential to alleviate these symptoms deserve thorough investigation.

This study will last 3 weeks. Participants in this study will be randomly assigned to receive six sessions of either moving or nonmoving touch therapy, in addition to usual hospice care, for 2 weeks. Moving touch therapy consists of massage therapy in which a trained therapist continually touches a person’s body. The nonmoving touch therapy will be conducted by volunteers who have no previous experience in massage. Participants in this group will have a volunteer rub specific body parts for 3-minute intervals. Because current evidence suggests that thoughts of healing may influence the effectiveness of touch therapy, volunteers in the nonmoving therapy group will distract their minds to avoid thinking of healing processes. In both groups, the person administering the touch therapy will note all interruptions during a session, including talk, music, and television. Interviews about medication use, pain, and quality of life will be used to assess participants; these interviews will be conducted at study start, immediately before and after each therapy session, and at Weeks 1, 2, and 3.

Status: Completed (Phase 2). Started on November 1st, 2003. Ended on March 1st, 2007.

Enrollment: 440 subjects

Study Type: Interventional

Study Design:

  • Treatment
  • Randomized
  • Single Blind
  • Active Control
  • Parallel Assignment
  • Efficacy Study

Conditions:

Interventions:

  • Procedure: Moving touch therapy
  • Procedure: Nonmoving touch therapy

Eligibility

Inclusion Criteria:

  • Advanced cancer, with at least moderate pain 1 week prior to study entry

  • Life expectancy of at least 3 weeks

  • Able to speak English

Exclusion Criteria:

  • Massage therapy within 1 month prior to study entry

  • Current use of anticoagulants

  • Platelet count less than 10,000

  • Unstable spine that would interfere with touch therapy

Gender

Both

Mininum Age

18 Years

Maximum Age

N/A

Healthy Volunteers

No


Resources

Source: National Center for Complementary and Alternative Medicine (NCCAM)

Authority: United States: Federal Government

Locations

  • San Diego Hospice
    San Diego
    California
    92103
    United States
  • University of Colorado Cancer Center
    Denver
    Colorado
    80262
    United States
  • Hospice of St. John
    Lakewood
    Colorado
    80215
    United States
  • Pike's Peak Hospice and Palliative Care
    Colorado Springs
    Colorado
    80903
    United States
  • Pathways at Hospice of Metro Denver
    Denver
    Colorado
    80246
    United States
  • Hope Hospice and Palliative Care
    Fort Myers
    Florida
    33908
    United States
  • LifePath Hospice and Palliative Care, Inc.
    Tampa
    Florida
    33609
    United States
  • Hospice Care in the Berkshires, Inc.
    Pittsfield
    Massachusetts
    01201
    United States
  • Hospice at Charlotte
    Charlotte
    North Carolina
    28204
    United States

Officials

  • Jean S. Kutner, MD (Principal Investigator, University of Colorado at Denver and Health Sciences Center)

  • Marlaine Smith, RN, PhD (Principal Investigator, University of Colorado at Denver and Health Sciences Center)

Sponsors

  • National Center for Complementary and Alternative Medicine (NCCAM) (Lead Sponsor)

References

None.

Links


Date Verified
January 1st, 2008
First Received
January 23rd, 2008
Last Changed
January 23rd, 2008

Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.


All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.

The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2010. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.